Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-24

Clinical Trial Update: Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether guanfacine affects opioid-induced hyperalgesia and tolerance has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Chronic Pain | Phase 4 | Status: TERMINATED